Thursday, October 13, 2022 | 12:00 PM - 1:00 PM EST
Join us for a discussion focusing on the latest biotech investment trends and sector outlook in the current challenging environment from the perspective of our sell side analyst guest speakers, Josh Schimmer, Evercore ISI, and Andrew Tsai, Jefferies. They will offer invaluable insight and some predictions about what to expect in 2023.
The speakers will explore topics around company positioning, public or private, for a favorable investment profile including:
Stage of pipeline development
Timing for the next expected data readouts
Positioning in the most exciting MOAs
Exposure to appealing disease targets
Access to capital
Quality of existing investors
Depth of management experience
SPEAKERS - Click on name for bio
Josh Schimmer Evercore ISI Fundamental Research Analyst
